NCT05370495View on ClinicalTrials.gov

Study of SY-201 Ophthalmic Solution in Subjects With Dry Eye Disease

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

201

Participants

Timeline

Start Date

July 25, 2022

Primary Completion Date

March 24, 2023

Study Completion Date

March 24, 2023

Conditions
Dry Eye Disease
Interventions
DRUG

SY-201 Ophthalmic Solution 2.0%

SY-201 Ophthalmic Solution 2.0%

DRUG

SY-201 Ophthalmic Solution 1.0%

SY-201 Ophthalmic Solution 1.0%

DRUG

SY-201 Ophthalmic Solution 0.5%

SY-201 Ophthalmic Solution 0.5%

DRUG

SY-201 Ophthalmic Solution Vehicle

SY-201 Ophthalmic Solution Vehicle

Trial Locations (1)

27703

Lexitas, Durham

All Listed Sponsors
lead

Seinda Pharmaceutical Guangzhou Corporation

INDUSTRY